Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years.

Saved in:
Bibliographic Details
Title: Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years.
Authors: Alrifai, D.1, Harper-Wynne, C.1, Jyothirmayi, R.1, Burcombe, R.1
Source: Clinical Oncology. May2016, Vol. 28 Issue 5, pe2-e2. 1p.
Database: Academic Search Ultimate
Description
ISSN:09366555
DOI:10.1016/j.clon.2016.01.017